Chemotherapy of human oncogenic viral infections: the possible role of interferon and reverse transcriptase inhibitors.
D000547:Amantadine; D000998:Antiviral Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004267:DNA Viruses; D004279:DNA, Viral; D003609:Dactinomycin / Q000494:pharmacology; D006801:Humans; D007369:Interferon Inducers; D007372:Interferons / Q000096:biosynthesis / Q000302:isolation & purification / Q000627:therapeutic use*; D009858:Oncogenic Viruses / Q000187:drug effects / Q000378:metabolism; D011070:Poly I-C; D012328:RNA Viruses; D012367:RNA, Viral; D012194:RNA-Directed DNA Polymerase / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins; D013310:Streptovaricin; D014764:Viral Proteins / Q000096:biosynthesis; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication
D000998:Antiviral Agents; D004279:DNA, Viral; D007369:Interferon Inducers; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins; D014764:Viral Proteins; D013310:Streptovaricin; D003609:Dactinomycin; D007372:Interferons; D000547:Amantadine; D012194:RNA-Directed DNA Polymerase; D011070:Poly I-C